Over-the-Counter Drugs-Global Market Status and Trend Report 2013-2023
Report Summary
Over-the-Counter Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Over-the-Counter Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Over-the-Counter Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Over-the-Counter Drugs worldwide, with company and product introduction, position in the Over-the-Counter Drugs market
Market status and development trend of Over-the-Counter Drugs by types and applications
Cost and profit status of Over-the-Counter Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Over-the-Counter Drugs market as:
Global Over-the-Counter Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Over-the-Counter Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Analgesics & Pain Relievers
Cough, Cold and Flu Products
Dermatological Products
Vitamin & Mineral Supplements
Gastrointestinal Products
Sleep Aids
Weight Loss Products
Smoking Cession Aids
Ophthalmic Products
Other
Global Over-the-Counter Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Over-the-Counter Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Over-the-Counter Drugs Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
Merck
Novartis
Pfizer
Sanofi
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
GlaxoSmithKline
Boehringer Ingelheim
Bayer
Alkem Laboratories
Glenmark Pharmaceuticals
Cipla
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Over-the-Counter Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Over-the-Counter Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Over-the-Counter Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Over-the-Counter Drugs worldwide, with company and product introduction, position in the Over-the-Counter Drugs market
Market status and development trend of Over-the-Counter Drugs by types and applications
Cost and profit status of Over-the-Counter Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Over-the-Counter Drugs market as:
Global Over-the-Counter Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Over-the-Counter Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Analgesics & Pain Relievers
Cough, Cold and Flu Products
Dermatological Products
Vitamin & Mineral Supplements
Gastrointestinal Products
Sleep Aids
Weight Loss Products
Smoking Cession Aids
Ophthalmic Products
Other
Global Over-the-Counter Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Over-the-Counter Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Over-the-Counter Drugs Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
Merck
Novartis
Pfizer
Sanofi
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
GlaxoSmithKline
Boehringer Ingelheim
Bayer
Alkem Laboratories
Glenmark Pharmaceuticals
Cipla
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OVER-THE-COUNTER DRUGS
1.1 Definition of Over-the-Counter Drugs in This Report
1.2 Commercial Types of Over-the-Counter Drugs
1.2.1 Analgesics & Pain Relievers
1.2.2 Cough, Cold and Flu Products
1.2.3 Dermatological Products
1.2.4 Vitamin & Mineral Supplements
1.2.5 Gastrointestinal Products
1.2.6 Sleep Aids
1.2.7 Weight Loss Products
1.2.8 Smoking Cession Aids
1.2.9 Ophthalmic Products
1.2.10 Other
1.3 Downstream Application of Over-the-Counter Drugs
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Over-the-Counter Drugs
1.5 Market Status and Trend of Over-the-Counter Drugs 2013-2023
1.5.1 Global Over-the-Counter Drugs Market Status and Trend 2013-2023
1.5.2 Regional Over-the-Counter Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Over-the-Counter Drugs 2013-2017
2.2 Sales Market of Over-the-Counter Drugs by Regions
2.2.1 Sales Volume of Over-the-Counter Drugs by Regions
2.2.2 Sales Value of Over-the-Counter Drugs by Regions
2.3 Production Market of Over-the-Counter Drugs by Regions
2.4 Global Market Forecast of Over-the-Counter Drugs 2018-2023
2.4.1 Global Market Forecast of Over-the-Counter Drugs 2018-2023
2.4.2 Market Forecast of Over-the-Counter Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Over-the-Counter Drugs by Types
3.2 Sales Value of Over-the-Counter Drugs by Types
3.3 Market Forecast of Over-the-Counter Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Over-the-Counter Drugs by Downstream Industry
4.2 Global Market Forecast of Over-the-Counter Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Over-the-Counter Drugs Market Status by Countries
5.1.1 North America Over-the-Counter Drugs Sales by Countries (2013-2017)
5.1.2 North America Over-the-Counter Drugs Revenue by Countries (2013-2017)
5.1.3 United States Over-the-Counter Drugs Market Status (2013-2017)
5.1.4 Canada Over-the-Counter Drugs Market Status (2013-2017)
5.1.5 Mexico Over-the-Counter Drugs Market Status (2013-2017)
5.2 North America Over-the-Counter Drugs Market Status by Manufacturers
5.3 North America Over-the-Counter Drugs Market Status by Type (2013-2017)
5.3.1 North America Over-the-Counter Drugs Sales by Type (2013-2017)
5.3.2 North America Over-the-Counter Drugs Revenue by Type (2013-2017)
5.4 North America Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Over-the-Counter Drugs Market Status by Countries
6.1.1 Europe Over-the-Counter Drugs Sales by Countries (2013-2017)
6.1.2 Europe Over-the-Counter Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Over-the-Counter Drugs Market Status (2013-2017)
6.1.4 UK Over-the-Counter Drugs Market Status (2013-2017)
6.1.5 France Over-the-Counter Drugs Market Status (2013-2017)
6.1.6 Italy Over-the-Counter Drugs Market Status (2013-2017)
6.1.7 Russia Over-the-Counter Drugs Market Status (2013-2017)
6.1.8 Spain Over-the-Counter Drugs Market Status (2013-2017)
6.1.9 Benelux Over-the-Counter Drugs Market Status (2013-2017)
6.2 Europe Over-the-Counter Drugs Market Status by Manufacturers
6.3 Europe Over-the-Counter Drugs Market Status by Type (2013-2017)
6.3.1 Europe Over-the-Counter Drugs Sales by Type (2013-2017)
6.3.2 Europe Over-the-Counter Drugs Revenue by Type (2013-2017)
6.4 Europe Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Over-the-Counter Drugs Market Status by Countries
7.1.1 Asia Pacific Over-the-Counter Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Over-the-Counter Drugs Revenue by Countries (2013-2017)
7.1.3 China Over-the-Counter Drugs Market Status (2013-2017)
7.1.4 Japan Over-the-Counter Drugs Market Status (2013-2017)
7.1.5 India Over-the-Counter Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Over-the-Counter Drugs Market Status (2013-2017)
7.1.7 Australia Over-the-Counter Drugs Market Status (2013-2017)
7.2 Asia Pacific Over-the-Counter Drugs Market Status by Manufacturers
7.3 Asia Pacific Over-the-Counter Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Over-the-Counter Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Over-the-Counter Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Over-the-Counter Drugs Market Status by Countries
8.1.1 Latin America Over-the-Counter Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Over-the-Counter Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Over-the-Counter Drugs Market Status (2013-2017)
8.1.4 Argentina Over-the-Counter Drugs Market Status (2013-2017)
8.1.5 Colombia Over-the-Counter Drugs Market Status (2013-2017)
8.2 Latin America Over-the-Counter Drugs Market Status by Manufacturers
8.3 Latin America Over-the-Counter Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Over-the-Counter Drugs Sales by Type (2013-2017)
8.3.2 Latin America Over-the-Counter Drugs Revenue by Type (2013-2017)
8.4 Latin America Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Over-the-Counter Drugs Market Status by Countries
9.1.1 Middle East and Africa Over-the-Counter Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Over-the-Counter Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Over-the-Counter Drugs Market Status (2013-2017)
9.1.4 Africa Over-the-Counter Drugs Market Status (2013-2017)
9.2 Middle East and Africa Over-the-Counter Drugs Market Status by Manufacturers
9.3 Middle East and Africa Over-the-Counter Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Over-the-Counter Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Over-the-Counter Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF OVER-THE-COUNTER DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Over-the-Counter Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 OVER-THE-COUNTER DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Over-the-Counter Drugs by Major Manufacturers
11.2 Production Value of Over-the-Counter Drugs by Major Manufacturers
11.3 Basic Information of Over-the-Counter Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Over-the-Counter Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Over-the-Counter Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 OVER-THE-COUNTER DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Over-the-Counter Drugs Product
12.1.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 Merck
12.2.1 Company profile
12.2.2 Representative Over-the-Counter Drugs Product
12.2.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Merck
12.3 Novartis
12.3.1 Company profile
12.3.2 Representative Over-the-Counter Drugs Product
12.3.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Novartis
12.4 Pfizer
12.4.1 Company profile
12.4.2 Representative Over-the-Counter Drugs Product
12.4.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Pfizer
12.5 Sanofi
12.5.1 Company profile
12.5.2 Representative Over-the-Counter Drugs Product
12.5.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sanofi
12.6 Teva Pharmaceutical Industries
12.6.1 Company profile
12.6.2 Representative Over-the-Counter Drugs Product
12.6.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
12.7 Sun Pharmaceutical Industries
12.7.1 Company profile
12.7.2 Representative Over-the-Counter Drugs Product
12.7.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
12.8 GlaxoSmithKline
12.8.1 Company profile
12.8.2 Representative Over-the-Counter Drugs Product
12.8.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.9 Boehringer Ingelheim
12.9.1 Company profile
12.9.2 Representative Over-the-Counter Drugs Product
12.9.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
12.10 Bayer
12.10.1 Company profile
12.10.2 Representative Over-the-Counter Drugs Product
12.10.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Bayer
12.11 Alkem Laboratories
12.11.1 Company profile
12.11.2 Representative Over-the-Counter Drugs Product
12.11.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Alkem Laboratories
12.12 Glenmark Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Over-the-Counter Drugs Product
12.12.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Glenmark Pharmaceuticals
12.13 Cipla
12.13.1 Company profile
12.13.2 Representative Over-the-Counter Drugs Product
12.13.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Cipla
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OVER-THE-COUNTER DRUGS
13.1 Industry Chain of Over-the-Counter Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF OVER-THE-COUNTER DRUGS
14.1 Cost Structure Analysis of Over-the-Counter Drugs
14.2 Raw Materials Cost Analysis of Over-the-Counter Drugs
14.3 Labor Cost Analysis of Over-the-Counter Drugs
14.4 Manufacturing Expenses Analysis of Over-the-Counter Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Over-the-Counter Drugs in This Report
1.2 Commercial Types of Over-the-Counter Drugs
1.2.1 Analgesics & Pain Relievers
1.2.2 Cough, Cold and Flu Products
1.2.3 Dermatological Products
1.2.4 Vitamin & Mineral Supplements
1.2.5 Gastrointestinal Products
1.2.6 Sleep Aids
1.2.7 Weight Loss Products
1.2.8 Smoking Cession Aids
1.2.9 Ophthalmic Products
1.2.10 Other
1.3 Downstream Application of Over-the-Counter Drugs
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Over-the-Counter Drugs
1.5 Market Status and Trend of Over-the-Counter Drugs 2013-2023
1.5.1 Global Over-the-Counter Drugs Market Status and Trend 2013-2023
1.5.2 Regional Over-the-Counter Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Over-the-Counter Drugs 2013-2017
2.2 Sales Market of Over-the-Counter Drugs by Regions
2.2.1 Sales Volume of Over-the-Counter Drugs by Regions
2.2.2 Sales Value of Over-the-Counter Drugs by Regions
2.3 Production Market of Over-the-Counter Drugs by Regions
2.4 Global Market Forecast of Over-the-Counter Drugs 2018-2023
2.4.1 Global Market Forecast of Over-the-Counter Drugs 2018-2023
2.4.2 Market Forecast of Over-the-Counter Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Over-the-Counter Drugs by Types
3.2 Sales Value of Over-the-Counter Drugs by Types
3.3 Market Forecast of Over-the-Counter Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Over-the-Counter Drugs by Downstream Industry
4.2 Global Market Forecast of Over-the-Counter Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Over-the-Counter Drugs Market Status by Countries
5.1.1 North America Over-the-Counter Drugs Sales by Countries (2013-2017)
5.1.2 North America Over-the-Counter Drugs Revenue by Countries (2013-2017)
5.1.3 United States Over-the-Counter Drugs Market Status (2013-2017)
5.1.4 Canada Over-the-Counter Drugs Market Status (2013-2017)
5.1.5 Mexico Over-the-Counter Drugs Market Status (2013-2017)
5.2 North America Over-the-Counter Drugs Market Status by Manufacturers
5.3 North America Over-the-Counter Drugs Market Status by Type (2013-2017)
5.3.1 North America Over-the-Counter Drugs Sales by Type (2013-2017)
5.3.2 North America Over-the-Counter Drugs Revenue by Type (2013-2017)
5.4 North America Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Over-the-Counter Drugs Market Status by Countries
6.1.1 Europe Over-the-Counter Drugs Sales by Countries (2013-2017)
6.1.2 Europe Over-the-Counter Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Over-the-Counter Drugs Market Status (2013-2017)
6.1.4 UK Over-the-Counter Drugs Market Status (2013-2017)
6.1.5 France Over-the-Counter Drugs Market Status (2013-2017)
6.1.6 Italy Over-the-Counter Drugs Market Status (2013-2017)
6.1.7 Russia Over-the-Counter Drugs Market Status (2013-2017)
6.1.8 Spain Over-the-Counter Drugs Market Status (2013-2017)
6.1.9 Benelux Over-the-Counter Drugs Market Status (2013-2017)
6.2 Europe Over-the-Counter Drugs Market Status by Manufacturers
6.3 Europe Over-the-Counter Drugs Market Status by Type (2013-2017)
6.3.1 Europe Over-the-Counter Drugs Sales by Type (2013-2017)
6.3.2 Europe Over-the-Counter Drugs Revenue by Type (2013-2017)
6.4 Europe Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Over-the-Counter Drugs Market Status by Countries
7.1.1 Asia Pacific Over-the-Counter Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Over-the-Counter Drugs Revenue by Countries (2013-2017)
7.1.3 China Over-the-Counter Drugs Market Status (2013-2017)
7.1.4 Japan Over-the-Counter Drugs Market Status (2013-2017)
7.1.5 India Over-the-Counter Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Over-the-Counter Drugs Market Status (2013-2017)
7.1.7 Australia Over-the-Counter Drugs Market Status (2013-2017)
7.2 Asia Pacific Over-the-Counter Drugs Market Status by Manufacturers
7.3 Asia Pacific Over-the-Counter Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Over-the-Counter Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Over-the-Counter Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Over-the-Counter Drugs Market Status by Countries
8.1.1 Latin America Over-the-Counter Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Over-the-Counter Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Over-the-Counter Drugs Market Status (2013-2017)
8.1.4 Argentina Over-the-Counter Drugs Market Status (2013-2017)
8.1.5 Colombia Over-the-Counter Drugs Market Status (2013-2017)
8.2 Latin America Over-the-Counter Drugs Market Status by Manufacturers
8.3 Latin America Over-the-Counter Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Over-the-Counter Drugs Sales by Type (2013-2017)
8.3.2 Latin America Over-the-Counter Drugs Revenue by Type (2013-2017)
8.4 Latin America Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Over-the-Counter Drugs Market Status by Countries
9.1.1 Middle East and Africa Over-the-Counter Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Over-the-Counter Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Over-the-Counter Drugs Market Status (2013-2017)
9.1.4 Africa Over-the-Counter Drugs Market Status (2013-2017)
9.2 Middle East and Africa Over-the-Counter Drugs Market Status by Manufacturers
9.3 Middle East and Africa Over-the-Counter Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Over-the-Counter Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Over-the-Counter Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Over-the-Counter Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF OVER-THE-COUNTER DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Over-the-Counter Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 OVER-THE-COUNTER DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Over-the-Counter Drugs by Major Manufacturers
11.2 Production Value of Over-the-Counter Drugs by Major Manufacturers
11.3 Basic Information of Over-the-Counter Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Over-the-Counter Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Over-the-Counter Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 OVER-THE-COUNTER DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Over-the-Counter Drugs Product
12.1.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 Merck
12.2.1 Company profile
12.2.2 Representative Over-the-Counter Drugs Product
12.2.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Merck
12.3 Novartis
12.3.1 Company profile
12.3.2 Representative Over-the-Counter Drugs Product
12.3.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Novartis
12.4 Pfizer
12.4.1 Company profile
12.4.2 Representative Over-the-Counter Drugs Product
12.4.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Pfizer
12.5 Sanofi
12.5.1 Company profile
12.5.2 Representative Over-the-Counter Drugs Product
12.5.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sanofi
12.6 Teva Pharmaceutical Industries
12.6.1 Company profile
12.6.2 Representative Over-the-Counter Drugs Product
12.6.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
12.7 Sun Pharmaceutical Industries
12.7.1 Company profile
12.7.2 Representative Over-the-Counter Drugs Product
12.7.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
12.8 GlaxoSmithKline
12.8.1 Company profile
12.8.2 Representative Over-the-Counter Drugs Product
12.8.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.9 Boehringer Ingelheim
12.9.1 Company profile
12.9.2 Representative Over-the-Counter Drugs Product
12.9.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
12.10 Bayer
12.10.1 Company profile
12.10.2 Representative Over-the-Counter Drugs Product
12.10.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Bayer
12.11 Alkem Laboratories
12.11.1 Company profile
12.11.2 Representative Over-the-Counter Drugs Product
12.11.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Alkem Laboratories
12.12 Glenmark Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Over-the-Counter Drugs Product
12.12.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Glenmark Pharmaceuticals
12.13 Cipla
12.13.1 Company profile
12.13.2 Representative Over-the-Counter Drugs Product
12.13.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Cipla
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OVER-THE-COUNTER DRUGS
13.1 Industry Chain of Over-the-Counter Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF OVER-THE-COUNTER DRUGS
14.1 Cost Structure Analysis of Over-the-Counter Drugs
14.2 Raw Materials Cost Analysis of Over-the-Counter Drugs
14.3 Labor Cost Analysis of Over-the-Counter Drugs
14.4 Manufacturing Expenses Analysis of Over-the-Counter Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
